Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?

Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?

Abstract Background Tumour budding (TB) and Tumour Stroma Ratio (TSR) may be rewarding in the treatment stratification of patients with stage II colon cancer. However, lack of standardization may exclude these parameters from being used in a clinical setting. The purpose of this methodologic study w...

Full description

Bibliographic Details
Main Authors: Ann C. Eriksen, Johnnie B. Andersen, Jan Lindebjerg, René dePont Christensen, Torben F. Hansen, Sanne Kjær-Frifeldt, Flemming B. Sørensen
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Diagnostic Pathology
Subjects:
Colon cancer
Heterogeneity
Tumour budding
Tumour stroma ratio
Online Access:http://link.springer.com/article/10.1186/s13000-018-0697-9

Internet

http://link.springer.com/article/10.1186/s13000-018-0697-9

Similar Items